AU2001249398A1 - Bicyclic sulfonyl amino inhibitors of factor xa - Google Patents

Bicyclic sulfonyl amino inhibitors of factor xa

Info

Publication number
AU2001249398A1
AU2001249398A1 AU2001249398A AU4939801A AU2001249398A1 AU 2001249398 A1 AU2001249398 A1 AU 2001249398A1 AU 2001249398 A AU2001249398 A AU 2001249398A AU 4939801 A AU4939801 A AU 4939801A AU 2001249398 A1 AU2001249398 A1 AU 2001249398A1
Authority
AU
Australia
Prior art keywords
factor
sulfonyl amino
inhibitors
bicyclic
bicyclic sulfonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001249398A
Inventor
Wenhao Li
Charles K. Marlowe
Robert M. Scarborough Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COR Therapeutics Inc
Original Assignee
COR Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COR Therapeutics Inc filed Critical COR Therapeutics Inc
Publication of AU2001249398A1 publication Critical patent/AU2001249398A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001249398A 2000-03-24 2001-03-26 Bicyclic sulfonyl amino inhibitors of factor xa Abandoned AU2001249398A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19171500P 2000-03-24 2000-03-24
US60191715 2000-03-24
PCT/US2001/009375 WO2001072725A1 (en) 2000-03-24 2001-03-26 BICYCLIC SULFONYL AMINO INHIBITORS OF FACTOR Xa

Publications (1)

Publication Number Publication Date
AU2001249398A1 true AU2001249398A1 (en) 2001-10-08

Family

ID=22706642

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001249398A Abandoned AU2001249398A1 (en) 2000-03-24 2001-03-26 Bicyclic sulfonyl amino inhibitors of factor xa

Country Status (4)

Country Link
US (1) US20020019394A1 (en)
EP (1) EP1268452A1 (en)
AU (1) AU2001249398A1 (en)
WO (1) WO2001072725A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100390157C (en) 2002-11-08 2008-05-28 弗·哈夫曼-拉罗切有限公司 Substituted benzo (58743)
PT1569912E (en) 2002-12-03 2015-09-15 Pharmacyclics Llc 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
US20050203513A1 (en) * 2003-09-24 2005-09-15 Tae-Ahn Jahng Spinal stabilization device
GB0815781D0 (en) * 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815784D0 (en) * 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
JPWO2011118818A1 (en) * 2010-03-26 2013-07-04 味の素株式会社 Amidinoaniline derivatives
US10736321B2 (en) 2016-07-04 2020-08-11 Bayer Cropscience Aktiengesellschaft Benzosultams and analogues and their use as fungicides
CN113248438B (en) * 2021-05-17 2022-04-12 浙大城市学院 Pyrazole compound and preparation method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3303189A (en) * 1965-03-11 1967-02-07 Smith Kline French Lab 2, 1-benzothiazine-2, 2-dioxides
US3303190A (en) * 1965-03-11 1967-02-07 Smith Kline French Lab Novel dihydro-2, 1-benzothiazine-2, 2-dioxide compounds
IL110172A (en) * 1993-07-22 2001-10-31 Lilly Co Eli Bicyclic compounds and pharmaceutical compositions containing them
EP0937723A1 (en) * 1998-02-18 1999-08-25 Roche Diagnostics GmbH Novel sulfonamides, process for their preparation and medicaments containing them
AR015269A1 (en) * 1998-04-10 2001-04-18 Japan Tobacco Inc AMIDINIC COMPOUND AND PHARMACEUTICAL COMPOSITION, INHIBITOR OF THE SANGUINEA COAGULATION AND INHIBITOR OF THE XA FACTOR THAT UNDERSTAND IT
DE19816983A1 (en) * 1998-04-17 1999-10-21 Boehringer Ingelheim Pharma New bicyclic heteroaromatic amidine or nitrile compounds, used as thrombin inhibitors, antithrombotic agents or intermediates

Also Published As

Publication number Publication date
WO2001072725A1 (en) 2001-10-04
EP1268452A1 (en) 2003-01-02
US20020019394A1 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
AU2001249399A1 (en) Isoquinolone inhibitors of factor xa
AU6762400A (en) Inhibitors of factor xa
AU5723500A (en) Inhibitors of factor xa
AU5283700A (en) Inhibitors of factor xa
AU5155500A (en) Inhibitors of factor xa
AU3857300A (en) Inhibitors of factor xa
AU2002350217A1 (en) Glycinamides as factor xa inhibitors
AU2002365896A1 (en) SUBSTITUTED AMINO METHYL FACTOR Xa INHIBITORS
AU2001273040A1 (en) Factor xa inhibitors
AU2001234689A1 (en) Bivalent phenylene inhibitors of factor xa
AU5284000A (en) Inhibitors of factor xa
AU2001249397A1 (en) Oxindole inhibitors of factor xa
AU2002303264A1 (en) Fused heterocyclic inhibitors of factor xa
AU2001258305A1 (en) Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines
AU2001294824A1 (en) Piperazine based inhibitors of factor xa
AU2002322802A1 (en) Thrombin inhibitors
AU2001281843A1 (en) Dipeptide inhibitors for the blood-clotting factor Xa
AU2001249398A1 (en) Bicyclic sulfonyl amino inhibitors of factor xa
AU2002306734A1 (en) Inhibitors of plasmepsins
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU2002214546A1 (en) Bicyclic pyrimidin-4-one based inhibitors of factor xa
AU2002222933A1 (en) Inhibitors of factor xa
AU2002316552A1 (en) Inhibitor of t cell activation
AU2002348501A1 (en) Factor xa inhibitor
AU2002351076A1 (en) Thrombin inhibitors